Literature DB >> 21144918

Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.

Kedibone M Mothibeli1, Mignon du Plessis, Anne von Gottberg, Ellen Murphy, Susan K Hoiseth, Gary Zlotnick, Keith P Klugman.   

Abstract

Factor H binding protein (fHBP) is currently under investigation as a potential vaccine antigen for protection against meningococcal serogroup B (MenB) disease. This study describes the distribution of genotypes among all (n=58) MenB, and a total of 80 representative non-MenB (serogroups A, C, Y and W135) isolates causing invasive disease in South Africa in 2005 using fHBP sequence analysis, PorA, FetA and multilocus sequence typing. There was less fHBP diversity among non-MenB isolates compared to MenB isolates. fHBP subfamily variant A32 was the most common fHBP variant among MenB isolates and was represented by 17% (10/58) of the isolates, while fHBP variant B16 was the most prevalent variant among non-MenB strains and was represented by 40% (32/80) of isolates. Overall, subfamily B domain N6 (modular group I) was most prevalent (57%, 79/138). Twenty PorA and 16 FetA types were identified among MenB isolates whereas non-MenB serogroups were largely associated with specific serosubtypes. The most common MenB clonal complex (ST-41/44/lineage 3) was represented by 29% (17/58) of the MenB isolates, while each of the non-MenB serogroups had a major clone represented by at least 75% of the isolates within the serorogroup. Our data highlight that non-MenB meningococcal isolates also harbor fHBP.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21144918     DOI: 10.1016/j.vaccine.2010.11.072

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.

Authors:  Susanna Esposito; Alberto Zampiero; Leonardo Terranova; Valentina Montinaro; Alessia Scala; Valentina Ansuini; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

Review 2.  Revealing the molecular signatures of host-pathogen interactions.

Authors:  Chiea-Chuen Khor; Martin L Hibberd
Journal:  Genome Biol       Date:  2011-10-19       Impact factor: 13.583

3.  Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.

Authors:  Chivonne Moodley; Mignon du Plessis; Kedibone Ndlangisa; Linda de Gouveia; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  From genes to vaccine: A breakthrough in the prevention of meningococcal group B disease.

Authors:  Maria Major; Steven Moss; Ronald Gold
Journal:  Paediatr Child Health       Date:  2011-10       Impact factor: 2.253

5.  Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.

Authors:  Jane W Marsh; Kathleen A Shutt; Rolando Pajon; Mary M Tulenko; Stephen Liu; Rosemary A Hollick; Julia A Kiehlbauch; Thomas A Clark; David S Stephens; Kathryn E Arnold; Robert A Myers; Leonard W Mayer; Lee H Harrison
Journal:  Vaccine       Date:  2011-06-24       Impact factor: 3.641

6.  Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.

Authors:  Rolando Pajon; Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

7.  Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine.

Authors:  Elizabeth E Moran; Robert Burden; Joseph E Labrie; Zhiyun Wen; Xin-Min Wang; Wendell D Zollinger; Lan Zhang; Valerian B Pinto
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

Review 8.  Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

Authors:  Lisa K McNeil; Robert J Zagursky; Shuo L Lin; Ellen Murphy; Gary W Zlotnick; Susan K Hoiseth; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

9.  Conservation of meningococcal antigens in the genus Neisseria.

Authors:  Alessandro Muzzi; Marirosa Mora; Mariagrazia Pizza; Rino Rappuoli; Claudio Donati
Journal:  MBio       Date:  2013-06-11       Impact factor: 7.867

Review 10.  Broad vaccine protection against Neisseria meningitidis using factor H binding protein.

Authors:  Jamie Findlow; Christopher D Bayliss; Peter T Beernink; Ray Borrow; Paul Liberator; Paul Balmer
Journal:  Vaccine       Date:  2020-08-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.